Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.335NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.1.169NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.43NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.42NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
AE.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.442NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.1.75NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.51NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.106NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
D.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.593NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.438.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
AY.5.1 (Delta)SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-21947.1Singapore
B.1.160.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21947US
BA.2.86.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21947US
JN.1.18.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21947US
BA.2.3.20NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21925.5US
GK.11NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21925.5US
DJ.1.3NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21925.5US
BQ.1.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-21921China
B.1.160ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-21913.4Japan
B.1.476ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-21913.4Japan
DV.3ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-21913.4Japan
B.1.195NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-21908.2Germany
FY.6.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21879US
XBB.1.5.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.48NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EK.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.66NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GS.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.21.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.39NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EE.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ES.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.41NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.19.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.479NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.437NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.371NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.4.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.6.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HU.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used